Pharma in Healthcare
IBSA foundation fellowships shatter records with unprecedented global reach and opens 2026 call
IBSA Foundation (Institut Biochimique SA) for scientific research, recently announced a record-shattering year for its prestigious fellowship programme, drawing an unprecedented...
Acute myocardial infarction market is expected to hit growth stride at a CAGR of 13% during the forecast period (2026-2036) with new therapeutic innovations
Recently published acute myocardial infarction market insights report includes a comprehensive understanding of current treatment practices, acute myocardial infarction...
Charcot-Marie-Tooth disease market growth to accelerate significantly during the forecast period (2026-2036) driven by the launch of emerging disease-modifying therapies
Recently published Charcot–Marie–Tooth Disease Market Insights report includes a comprehensive understanding of current treatment practices, Charcot–Marie–Tooth disease emerging drugs,...
Tyra Biosciences and the Bladder Cancer Advocacy Network have established 21 May as upper tract urothelial cancer awareness day
Tyra Biosciences has announced the establishment of Upper Tract Urothelial Cancer (UTUC) Awareness Day, in collaboration with the Bladder...
Valion Bio briefs senior Department of War and BARDA officials in joint engagement on Entolimod for acute radiation syndrome
Valion Bio, a late-stage innate immunotherapeutics company, has announced that it presented Entolimod for acute radiation syndrome (ARS) to senior...
Global Alzheimer’s therapeutics market expands at 9.3% CAGR as biologics and early diagnosis transform dementia care
The global Alzheimer's therapeutics market is projected to grow from US$ 4.3 billion in 2026 to US$ 10.4 billion by 2036, expanding at...
Marty Makary resigns as chief of the Food and Drug Administration
Marty Makary, US Food and Drug Administration (FDA) commissioner, is leaving his post, US president Donald Trump said yesterday...
US$ 8.5 million investment in malaria and other R&D projects planned among pharma giants
The global health innovative technology (GHIT) fund has announced a total investment of approximately JPY 1.37 billion (US$ 8.5...
MHRA approves new high dose regimen of Spinraza (nusinersen) for spinal muscular atrophy
Biogen announces that the high dose regimen of Spinraza® (nusinersen), has been approved by the Medicines and Healthcare Products Regulatory...
Cell line development market to reach $8.95 billion by 2031 with Gene & Cell Therapy manufacturing growing at 10.88%
According to Mordor Intelligence, the global cell line development market is projected to grow from USD 4.97 billion in 2025 to USD 5.48 billion in...
Romaco Group appoints Nicola Magriotis as Chief Sales Officer
The advisory board of Romaco Holding GmbH has appointed Nicola Magriotis as Chief Sales Officer (CSO) of the Romaco...
New report finds FDA costs soaring and drug rejections rising
The Taxpayers Protection Alliance released a report, called Blocking Breakthroughs: Delays and Denials at the FDA, that highlights the many issues...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
Popular
© 2026 Pharma Press Publishing.